US Stock MarketDetailed Quotes
PBM Psyence Biomedical
- 0.537
- +0.008+1.53%
Close Aug 16 16:00 ET
- 0.515
- -0.022-4.06%
Post 20:01 ET
8.87MMarket Cap-140P/E (TTM)
0.551High0.522Low117.72KVolume0.530Open0.529Pre Close62.57KTurnover1.09%Turnover RatioLossP/E (Static)16.52MShares14.55052wk High-0.81P/B5.79MFloat Cap0.26752wk Low--Dividend TTM10.79MShs Float14.550Historical High--Div YieldTTM5.48%Amplitude0.267Historical Low0.531Avg Price1Lot Size
Psyence Biomedical Key Stats
Quarterly+Annual
YOY
| (FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | |
|---|---|---|---|
| Operating Cash Flow (Indirect Method) | |||
| Cash flow from continuing operating activities | -85.00%-2.95M | -14.01%-1.59M | -1.4M |
| Net income from continuing operations | -1,495.53%-51.16M | -72.55%-3.21M | ---1.86M |
| Operating gains losses | 133.62%28.41K | ---84.5K | ---- |
| Depreciation and amortization | --240 | --0 | ---- |
| Other non cash items | --43.58M | ---- | ---- |
| Change In working capital | -179.39%-1.17M | 1,038.80%1.48M | --129.74K |
| -Change in receivables | 197.96%107.62K | -209.80%-109.86K | --100.05K |
| -Change in prepaid assets | -241.97%-245.08K | -56,019.30%-71.67K | --128.1579 |
| -Change in payables and accrued expense | -162.41%-1.04M | 5,511.67%1.66M | --29.56K |
| Cash from discontinued investing activities | |||
| Operating cash flow | -85.00%-2.95M | -14.01%-1.59M | ---1.4M |
| Investing cash flow | |||
| Cash flow from continuing investing activities | -5.73K | 0 | -32.04K |
| Net PPE purchase and sale | ---5.73K | --0 | ---- |
| Net other investing changes | ---- | ---- | ---32.04K |
| Cash from discontinued investing activities | |||
| Investing cash flow | ---5.73K | --0 | ---32.04K |
| Financing cash flow | |||
| Cash flow from continuing financing activities | 100.35%2.35M | 172.07%1.17M | -1.63M |
| Net issuance payments of debt | --2.35M | --0 | ---- |
| Net other financing activities | ---- | 172.07%1.17M | ---1.63M |
| Cash from discontinued financing activities | |||
| Financing cash flow | 100.35%2.35M | 172.07%1.17M | ---1.63M |
| Net cash flow | |||
| Beginning cash position | -23.90%1.33M | -63.55%1.75M | --4.81M |
| Current changes in cash | -43.40%-601.09K | 86.28%-419.16K | ---3.06M |
| End cash Position | -45.05%733.19K | -23.97%1.33M | --1.76M |
| Free cash flow | -85.36%-2.95M | -14.01%-1.59M | ---1.4M |
| Currency Unit | USD | USD | USD |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg